Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$78.44
neg -1.10
-1.40%
Today's Range: 78.18 - 79.99 | LLY Avg Daily Volume: 3,960,100
Last Update: 08/24/16 - 3:59 PM EDT
Volume: 2,795,979
YTD Performance: -5.57%
Open: $79.60
Previous Close: $79.57
52 Week Range: $67.88 - $92.85
Oustanding Shares: 1,103,843,444
Market Cap: 87,523,746,675
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 8 8 9
Moderate Buy 0 0 0 0
Hold 3 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.77 1.92 1.92 1.86
Latest Dividend: 0.51
Latest Dividend Yield: 2.57%
Dividend Ex-Date: 08/11/16
Price Earnings Ratio: 34.03
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
34.03 36.40 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.41% -5.87% 51.22%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.70 -0.10 -0.04
Net Income 0.70 -0.40 -0.16
EPS 1.60 -0.40 -0.15
Earnings for LLY:
EBITDA 4.48B
Revenue 19.96B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $0.94 $0.98 $3.58 $4.08
Number of Analysts 5 5 10 10
High Estimate $0.97 $1.05 $3.66 $4.28
Low Estimate $0.91 $0.93 $3.54 $3.87
Prior Year $0.89 $0.78 $3.43 $3.58
Growth Rate (Year over Year) 5.84% 25.13% 4.40% 13.80%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Skip Raschke

 | Aug 22, 2016 | 7:00 AM EDT
Consider that the $70 line of support.
By

Jim Cramer

 | Aug 17, 2016 | 8:09 AM EDT
Be aware that Johnson & Johnson, American Electric Power and Federal Realty don't roll over idly.
By

Dick Arms

 | Aug 11, 2016 | 7:00 AM EDT
The market action looks very much like it did before the drops that occurred in 2000 and 2008.
By

Jim Cramer

 | Aug 10, 2016 | 1:11 PM EDT
Jim Cramer says Eli Lilly has been overpromising and underdelivering.
By

James "Rev Shark" DePorre

 | Aug 10, 2016 | 10:36 AM EDT
I'm not inclined to make market calls, but the action on my screen is pushing me to a defensive stance.
By

Bruce Kamich

 | Aug 10, 2016 | 8:01 AM EDT
If buyers don't appear around $78 then a deeper correction is likely.
By

Tony Owusu

 | Jul 28, 2016 | 3:16 PM EDT
Facebook continued to reap the rewards of its strong quarterly results today.

bullishEli Lilly numbers raised at BMO

Jul 27, 2016 | 7:39 AM EDT
Shares of LLY now seen reaching $94, according to BMO Capital. Estimates also increased, as the company has potentially transformative pipeline assets. Outperform rating.
By

Jim Cramer

 | Jun 15, 2016 | 6:24 AM EDT

This is the group that is the most dangerous politically.

By

Bruce Kamich

 | May 31, 2016 | 2:58 PM EDT

Our quantitative service has upgraded the drug maker to a buy, but the technicals are not ready yet to join in.

AMZN is beginning to look vulnerable to a healthy pullback.  The stock has worked off...
The SMH looks completely exhausted.  Since the Aug. 3rd low the index has been steadi...
Out in San Francisco for the Money Show and about to do presentation on biotech investing,...
Enormous flow in SBUX this week, notably the Nov 57.5 strike, was more popular than a tick...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.